India needs holistic approach if it is to keep up with rivals in pharma nanotech, says BCG
This article was originally published in Scrip
Executive Summary
If it is to keep pace with China and Russia, India needs to put in place effective policies and systems, backed by vibrant funding options, to unlock potential in the nanotechnology segment, especially in oncology.